NO20000485L - Alatrofloxacin parenterale blandinger - Google Patents

Alatrofloxacin parenterale blandinger

Info

Publication number
NO20000485L
NO20000485L NO20000485A NO20000485A NO20000485L NO 20000485 L NO20000485 L NO 20000485L NO 20000485 A NO20000485 A NO 20000485A NO 20000485 A NO20000485 A NO 20000485A NO 20000485 L NO20000485 L NO 20000485L
Authority
NO
Norway
Prior art keywords
alatrofloxacin
parenteral mixtures
parenteral
mixtures
alatrofloxacin parenteral
Prior art date
Application number
NO20000485A
Other languages
English (en)
Norwegian (no)
Other versions
NO20000485D0 (no
Inventor
Robert Mark Guinn
John Francis Lambert
Subramanian Sam Guhan
Stanley Walter Walinsky
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20000485D0 publication Critical patent/NO20000485D0/no
Publication of NO20000485L publication Critical patent/NO20000485L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicinal Preparation (AREA)
NO20000485A 1997-08-01 2000-01-31 Alatrofloxacin parenterale blandinger NO20000485L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5424697P 1997-08-01 1997-08-01
PCT/IB1998/001122 WO1999006430A1 (en) 1997-08-01 1998-07-23 Alatrofloxacin parenteral compositions

Publications (2)

Publication Number Publication Date
NO20000485D0 NO20000485D0 (no) 2000-01-31
NO20000485L true NO20000485L (no) 2000-03-27

Family

ID=21989735

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000485A NO20000485L (no) 1997-08-01 2000-01-31 Alatrofloxacin parenterale blandinger

Country Status (40)

Country Link
US (1) US6194429B1 (es)
EP (1) EP1000086B1 (es)
JP (1) JP3463928B2 (es)
KR (1) KR20010022495A (es)
CN (1) CN1265671A (es)
AP (1) AP1031A (es)
AR (1) AR015417A1 (es)
AT (1) ATE259827T1 (es)
AU (1) AU734863B2 (es)
BG (1) BG104105A (es)
BR (1) BR9811580A (es)
CA (1) CA2296466C (es)
CO (1) CO4970688A1 (es)
DE (1) DE69821767T2 (es)
DK (1) DK1000086T3 (es)
DZ (1) DZ2576A1 (es)
EA (1) EA002120B1 (es)
ES (1) ES2214716T3 (es)
GT (1) GT199800112A (es)
HN (1) HN1998000106A (es)
HR (1) HRP980417B1 (es)
HU (1) HUP0004793A3 (es)
ID (1) ID24374A (es)
IL (1) IL134156A0 (es)
IS (1) IS5339A (es)
MA (1) MA24626A1 (es)
NO (1) NO20000485L (es)
NZ (1) NZ502249A (es)
OA (1) OA11281A (es)
PA (1) PA8456701A1 (es)
PE (1) PE103799A1 (es)
PL (1) PL338477A1 (es)
PT (1) PT1000086E (es)
SK (1) SK1012000A3 (es)
TN (1) TNSN98146A1 (es)
TW (1) TW538043B (es)
UY (1) UY25113A1 (es)
WO (1) WO1999006430A1 (es)
YU (1) YU2500A (es)
ZA (1) ZA986874B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302015B6 (cs) * 1999-10-08 2010-09-08 Affinium Pharmaceuticals, Inc. Inhibitory Fab I
EP1121933A1 (en) * 2000-02-02 2001-08-08 Pfizer Products Inc. Premixed alatrofloxacin injectable compositions
ATE420640T1 (de) * 2001-04-06 2009-01-15 Affinium Pharm Inc Fab-i-inhibitoren
DK1575951T3 (da) * 2002-12-06 2014-09-15 Debiopharm Int Sa Heterocykliske forbindelser, fremgangsmåder til fremstilling deraf og deres anvendelse i terapi
EP1608377B1 (en) 2003-03-17 2008-10-01 Affinium Pharmaceuticals, Inc. Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
CA2467321A1 (en) * 2004-05-14 2005-11-14 Paul J. Santerre Polymeric coupling agents and pharmaceutically-active polymers made therefrom
SI1828167T1 (sl) * 2004-06-04 2014-12-31 Debiopharm International Sa Forum "Apres-Demain" Akrilamidni derivati kot anitibiotična sredstva
WO2007067416A2 (en) * 2005-12-05 2007-06-14 Affinium Pharmaceuticals, Inc. Heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
EP2054422B1 (en) 2006-07-20 2017-06-14 Debiopharm International SA Acrylamide derivatives as fab i inhibitors
WO2008098374A1 (en) 2007-02-16 2008-08-21 Affinium Pharmaceuticals, Inc. Salts, prodrugs and polymorphs of fab i inhibitors
MX356695B (es) 2012-06-19 2018-06-11 Debiopharm Int Sa Profarmacos derivados de (e)-n-metil-n-((3-metilbenzofuran-2-il)me til)-3-(7-oxo-5,6,7,8-tetrahidro-1,8-naftiridin-3-il) acrilamida.
UA122204C2 (uk) * 2014-04-25 2020-10-12 Наурекс, Інк. Стабільні композиції нейроактивних пептидів
KR20180114177A (ko) 2016-02-26 2018-10-17 데비오팜 인터네셔날 에스 에이 당뇨병성 족부 감염의 치료제
CA3087898A1 (en) 2018-02-02 2019-08-08 Ripple Therapeutics Corporation Glass formulations comprising steroid dimers and uses thereof
CA3176134A1 (en) 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3713672A1 (de) 1987-04-24 1988-11-17 Bayer Ag Verfahren zur herstellung von parenteral verabreichbaren chinoloncarbonsaeuren
US5164402A (en) 1989-08-16 1992-11-17 Pfizer Inc Azabicyclo quinolone and naphthyridinone carboxylic acids
US5256791A (en) 1992-03-02 1993-10-26 Pfizer Inc. Preparation of intermediates in the synthesis of quinoline antibiotics
EP0740667A1 (en) 1994-01-18 1996-11-06 Pfizer Inc. Process and intermediates for preparing naphthyridonecarboxylic acid salts
TW420610B (en) 1994-04-07 2001-02-01 Pfizer A pharmaceutical composition for treating a H. pylori infection or gastric or duodenal ulcers
US5475116A (en) 1994-04-29 1995-12-12 Pfizer Inc. Aza bicyclo[3,1,0]hexane intermediates useful in the synthesis of quinolones
CA2223404C (en) 1995-06-06 2001-01-16 Thomas A. Morris Novel crystal form of anhydrous 7-(¬1.alpha., 5.alpha., 6.alpha.|-6-amino-3-azabicyclo¬3.1.0|hex-3-yl)-6-fluoro-1-(2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, methanesulfonic acid salt
DK0833837T3 (da) * 1995-06-15 2002-09-02 Pfizer Fremgangsmåde til fremstilling af derivater af azabicyclonaphthydridincarboxylsyre omfattende et dipeptid
NZ310542A (en) * 1995-08-29 1999-09-29 Pfizer Polymorphs of the prodrug 6-n-(l-ala-l-ala)-trovafloxacin selected from its polymorph, its pseodomorphs and the monohydrate, preparation and pharmaceutical compositions thereof
PL325170A1 (en) 1995-08-29 1998-07-06 Pfizer Bipolar forms of throwaflocacin
GB9524466D0 (en) 1995-11-30 1996-01-31 Pfizer Ltd Process
JPH1087617A (ja) 1996-07-09 1998-04-07 Pfizer Inc キノリン系抗生物質の合成に有用な中間体の製法

Also Published As

Publication number Publication date
DZ2576A1 (fr) 2003-02-22
IL134156A0 (en) 2001-04-30
CA2296466C (en) 2003-04-15
PA8456701A1 (es) 2000-05-24
HN1998000106A (es) 1999-01-08
BG104105A (bg) 2000-08-31
NZ502249A (en) 2001-11-30
YU2500A (sh) 2002-09-19
KR20010022495A (ko) 2001-03-15
US6194429B1 (en) 2001-02-27
AR015417A1 (es) 2001-05-02
DK1000086T3 (da) 2004-05-17
SK1012000A3 (en) 2000-09-12
CO4970688A1 (es) 2000-11-07
AP9801310A0 (en) 1998-09-30
PE103799A1 (es) 1999-10-25
AU734863B2 (en) 2001-06-21
MA24626A1 (fr) 1999-04-01
JP2001512133A (ja) 2001-08-21
AP1031A (en) 2001-12-21
DE69821767T2 (de) 2005-01-13
EA002120B1 (ru) 2001-12-24
NO20000485D0 (no) 2000-01-31
HUP0004793A2 (hu) 2001-04-28
HUP0004793A3 (en) 2001-10-29
HRP980417B1 (en) 2002-10-31
WO1999006430A1 (en) 1999-02-11
UY25113A1 (es) 2000-12-29
ATE259827T1 (de) 2004-03-15
IS5339A (is) 2000-01-14
ZA986874B (en) 2000-01-31
DE69821767D1 (de) 2004-03-25
CA2296466A1 (en) 1999-02-11
ID24374A (id) 2000-07-13
ES2214716T3 (es) 2004-09-16
TNSN98146A1 (fr) 2005-03-15
JP3463928B2 (ja) 2003-11-05
BR9811580A (pt) 2000-08-22
GT199800112A (es) 2000-01-15
EP1000086A1 (en) 2000-05-17
CN1265671A (zh) 2000-09-06
PT1000086E (pt) 2004-05-31
OA11281A (en) 2002-11-19
PL338477A1 (en) 2000-11-06
TW538043B (en) 2003-06-21
HRP980417A2 (en) 1999-08-31
EP1000086B1 (en) 2004-02-18
AU8236898A (en) 1999-02-22
EA200000086A1 (ru) 2000-08-28

Similar Documents

Publication Publication Date Title
NO985337L (no) Tetrahydrolipstatin-holdige blandinger
DE69802448T2 (de) Riemenspanner
EE200000291A (et) 2-fenüülasendatud imidasotriasinoonid
NO982686D0 (no) R°rledningsplugg
NO995360L (no) Strekkanordning
PT938496E (pt) Misturas insecticidas sinergicas
DE59806422D1 (de) Partikelfreies gaserzeugendes Gemisch
DE69802367T2 (de) Plattierungsverfahren
NO20000485D0 (no) Alatrofloxacin parenterale blandinger
DE69805018D1 (de) Riemenspanner
IS2150B (is) Statín-karboxýalkýleter-blöndur
DE69801123D1 (de) Riemenspanner
DE69817958D1 (de) Zahnriemen
NO974175L (no) B°lgekraftverk
NO20002555L (no) Skjøt
DE69835157D1 (de) Reihenelektroden-anodisierung
NO974892L (no) Ventilasjonsr°r
FI973961A0 (fi) Lyft- och belastningsanordning foer en valsstapel i en kalander
ATA65497A (de) Bauelement
FR2770103B1 (fr) Bigoudi perfectionne
KR970053244U (ko) 혁대
KR970012429U (ko) 책갈피
BR7700451U (pt) Acessório monipassafio
FIU970229U0 (fi) Asiapaperikansio
SE9703419D0 (sv) Arrangemang

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application